U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07633171) titled 'Multimodal Glucose Prediction in Type 2 Diabetes' on June 02.
Brief Summary: The primary objective of this research, funded by Samsung Strategic Alliance for Research and Technology, is to develop multi-modal foundation models that integrate Continuious Glucose Monitoring (CGM) data with patient behavior data (food intake, medication, and physical activity) to improve real-time glucose prediction and personalized diabetes management for patients with Type 2 diabetes (T2D), delivered via mobile apps and digital health tools.
Study Start Date: June 15
Study Type: OBSERVATIONAL
Condition:
Type 2 Diabetes
Intervention:
DEVICE: Digi...